Clinical evaluation of Haridrakhand and Triphala Kwath in the management of Chronic Allergic Conjunctivitis

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 55 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients of either sex with age between 18 and 60 years.
•2.Patients presenting with signs and symptoms of Chronic Allergic Conjunctivitis having history of seasonal or perennial allergic conjunctivitis for at least 1 year on the basis of objective and subjective parameters i.e.-
•iii.Lacrimation
•iv.Photophobia
•v.FB Sensation
•vi.Burning Sensation
•vii.Lid Swelling
•3. Patients willing to participate and give written informed consent to participate in the study for 10 weeks including 2 weeks without drug follow-up

•1)Patients having associated marginal corneal ulcer, Dacryocystitis, Trachoma, Kerato-Conjunctivitis, infective conjunctivitis, allergic to dyes and seborrhic Blepharitis, dandruffs etc.
•2)Patients positive for conjunctival smear and culture to exclude any infective occurrence.
•3)Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit.
•4)Patients having serious Renal Dysfunction, uncontrolled Pulmonary Dysfunction, (asthmatic and COPD patients) or other concurrent severe disease.
•5)Patients with uncontrolled Diabetes Mellitus (Blood Sugar Fasting > 250 mg/dl)
•6)Patients with poorly controlled Hypertension ( > 160/100 mmHg).
•7)Pregnant / lactating females.
•8)Patients on steroids, oral contraceptives, or estrogen replacement therapy.
•9)Smokers/Alcoholics and/or drug abusers.
•10)Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro - Endocrinal disorders, etc.).
•11)H/o hypersensitivity to the trial drug or any of its ingredients.
•12)Patients who have completed participation in any other clinical trial during the past six (06) months.
•13)Any other condition which the Investigator thinks may jeopardize the study.

发起方